Cargando…

Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation

Pulsed field ablation (PFA) is a uniquely tissue-selective, nonthermal cardiac ablation modality. Delivery parameters such as the electrical waveform composition and device design are critical to PFA’s efficacy and safety, particularly tissue specificity. In a series of preclinical studies, we sough...

Descripción completa

Detalles Bibliográficos
Autores principales: Koruth, Jacob, Kuroki, Kenji, Iwasawa, Jin, Enomoto, Yoshinari, Viswanathan, Raju, Brose, Richard, Buck, Eric D., Speltz, Molly, Dukkipati, Srinivas R., Reddy, Vivek Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924932/
https://www.ncbi.nlm.nih.gov/pubmed/31826647
http://dx.doi.org/10.1161/CIRCEP.119.007781
_version_ 1783481820888694784
author Koruth, Jacob
Kuroki, Kenji
Iwasawa, Jin
Enomoto, Yoshinari
Viswanathan, Raju
Brose, Richard
Buck, Eric D.
Speltz, Molly
Dukkipati, Srinivas R.
Reddy, Vivek Y.
author_facet Koruth, Jacob
Kuroki, Kenji
Iwasawa, Jin
Enomoto, Yoshinari
Viswanathan, Raju
Brose, Richard
Buck, Eric D.
Speltz, Molly
Dukkipati, Srinivas R.
Reddy, Vivek Y.
author_sort Koruth, Jacob
collection PubMed
description Pulsed field ablation (PFA) is a uniquely tissue-selective, nonthermal cardiac ablation modality. Delivery parameters such as the electrical waveform composition and device design are critical to PFA’s efficacy and safety, particularly tissue specificity. In a series of preclinical studies, we sought to examine the electrophysiological and histological effects of PFA and compare the safety and feasibility of durable pulmonary vein and superior vena cava (SVC) isolation between radiofrequency ablation and PFA waveforms. METHODS: A femoral venous approach was used to gain right and left atrial access under general anesthesia in healthy swine. Baseline potentials in right superior pulmonary and inferior common vein and in SVC were assessed. Bipolar PFA was performed with monophasic (PFA(Mono)) and biphasic (PFA(Bi)) waveforms in 7 and 7 swine sequentially and irrigated radiofrequency ablation in 3 swine. Vein potentials were then assessed acutely, and at ≈10 weeks; histology was obtained. RESULTS: All targeted veins (n=46) were successfully isolated on the first attempt in all cohorts. The PFA(Bi) waveform induced significantly less skeletal muscle engagement. Pulmonary vein isolation durability was assessed in 28 veins: including the SVC, durability was significantly higher in the PFA(Bi) group (18/18 PFA(Bi), 10/18 PFA(Mono), 3/6 radiofrequency, P=0.002). Transmurality rates were similar across groups with evidence of nerve damage only with radiofrequency. Pulmonary vein narrowing was noted only in the radiofrequency cohort. The phrenic nerve was spared in all cohorts but at the expense of incomplete SVC encirclement with radiofrequency. CONCLUSIONS: In this chronic porcine study, PFA-based pulmonary vein and SVC isolation were safe and efficacious with demonstrable sparing of nerves and venous tissue. This preclinical study provided the scientific basis for the first-in-human endocardial PFA studies.
format Online
Article
Text
id pubmed-6924932
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-69249322020-01-23 Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation Koruth, Jacob Kuroki, Kenji Iwasawa, Jin Enomoto, Yoshinari Viswanathan, Raju Brose, Richard Buck, Eric D. Speltz, Molly Dukkipati, Srinivas R. Reddy, Vivek Y. Circ Arrhythm Electrophysiol Original Articles Pulsed field ablation (PFA) is a uniquely tissue-selective, nonthermal cardiac ablation modality. Delivery parameters such as the electrical waveform composition and device design are critical to PFA’s efficacy and safety, particularly tissue specificity. In a series of preclinical studies, we sought to examine the electrophysiological and histological effects of PFA and compare the safety and feasibility of durable pulmonary vein and superior vena cava (SVC) isolation between radiofrequency ablation and PFA waveforms. METHODS: A femoral venous approach was used to gain right and left atrial access under general anesthesia in healthy swine. Baseline potentials in right superior pulmonary and inferior common vein and in SVC were assessed. Bipolar PFA was performed with monophasic (PFA(Mono)) and biphasic (PFA(Bi)) waveforms in 7 and 7 swine sequentially and irrigated radiofrequency ablation in 3 swine. Vein potentials were then assessed acutely, and at ≈10 weeks; histology was obtained. RESULTS: All targeted veins (n=46) were successfully isolated on the first attempt in all cohorts. The PFA(Bi) waveform induced significantly less skeletal muscle engagement. Pulmonary vein isolation durability was assessed in 28 veins: including the SVC, durability was significantly higher in the PFA(Bi) group (18/18 PFA(Bi), 10/18 PFA(Mono), 3/6 radiofrequency, P=0.002). Transmurality rates were similar across groups with evidence of nerve damage only with radiofrequency. Pulmonary vein narrowing was noted only in the radiofrequency cohort. The phrenic nerve was spared in all cohorts but at the expense of incomplete SVC encirclement with radiofrequency. CONCLUSIONS: In this chronic porcine study, PFA-based pulmonary vein and SVC isolation were safe and efficacious with demonstrable sparing of nerves and venous tissue. This preclinical study provided the scientific basis for the first-in-human endocardial PFA studies. Lippincott Williams & Wilkins 2019-12-12 /pmc/articles/PMC6924932/ /pubmed/31826647 http://dx.doi.org/10.1161/CIRCEP.119.007781 Text en © 2019 The Authors. Circulation: Arrhythmia and Electrophysiology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Original Articles
Koruth, Jacob
Kuroki, Kenji
Iwasawa, Jin
Enomoto, Yoshinari
Viswanathan, Raju
Brose, Richard
Buck, Eric D.
Speltz, Molly
Dukkipati, Srinivas R.
Reddy, Vivek Y.
Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation
title Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation
title_full Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation
title_fullStr Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation
title_full_unstemmed Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation
title_short Preclinical Evaluation of Pulsed Field Ablation: Electrophysiological and Histological Assessment of Thoracic Vein Isolation
title_sort preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924932/
https://www.ncbi.nlm.nih.gov/pubmed/31826647
http://dx.doi.org/10.1161/CIRCEP.119.007781
work_keys_str_mv AT koruthjacob preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT kurokikenji preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT iwasawajin preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT enomotoyoshinari preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT viswanathanraju preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT broserichard preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT buckericd preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT speltzmolly preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT dukkipatisrinivasr preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation
AT reddyviveky preclinicalevaluationofpulsedfieldablationelectrophysiologicalandhistologicalassessmentofthoracicveinisolation